| Literature DB >> 22846728 |
Julianne M O'Daniel1, Kristy Lee.
Abstract
The incorporation of whole-genome and whole-exome sequencing into clinical practice will undoubtedly change the way genetic counselors and other clinicians approach genetic testing. Enabling the analysis of essentially all human genes in one comprehensive test, this new technology can result in reduced testing cost and time to diagnosis. Another consequence of this broad scope, however, is the increased amount, complexity, and variety of results a clinician may need to discuss with a patient. The purpose of this article is to review the technology and outline some of the benefits and challenges of whole-genome and whole-exome sequencing in hereditary cancer practice.Entities:
Mesh:
Year: 2012 PMID: 22846728 DOI: 10.1097/PPO.0b013e318262467e
Source DB: PubMed Journal: Cancer J ISSN: 1528-9117 Impact factor: 3.360